Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
14.02 USD | +10.05% | +14.39% | -6.30% |
07:21pm | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
03:18pm | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.10% | 1.37B | |
+73.23% | 12.37B | |
-18.39% | 7.96B | |
+16.18% | 7.09B | |
+3.39% | 5.83B | |
+11.77% | 5.35B | |
+29.65% | 4.63B | |
-17.74% | 4B | |
-35.32% | 2.41B | |
+2.10% | 2B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Transcript : NovoCure Limited, Q4 2023 Earnings Call, Feb 22, 2024